Correlation Between GeneReach Biotechnology and Level Biotechnology

Can any of the company-specific risk be diversified away by investing in both GeneReach Biotechnology and Level Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GeneReach Biotechnology and Level Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between GeneReach Biotechnology and Level Biotechnology, you can compare the effects of market volatilities on GeneReach Biotechnology and Level Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GeneReach Biotechnology with a short position of Level Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of GeneReach Biotechnology and Level Biotechnology.

Diversification Opportunities for GeneReach Biotechnology and Level Biotechnology

0.08

Correlation Coefficient

GeneReach Biotechnology  Level Biotechnology

Significant diversification

The 3 months correlation between GeneReach and Level is 0.08. Overlapping area represents the amount of risk that can be diversified away by holding GeneReach Biotechnology and Level Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Level Biotechnology and GeneReach Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GeneReach Biotechnology are associated (or correlated) with Level Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Level Biotechnology has no effect on the direction of GeneReach Biotechnology i.e., GeneReach Biotechnology and Level Biotechnology go up and down completely randomly.

Pair Corralation between GeneReach Biotechnology and Level Biotechnology

Assuming the 90 days trading horizon GeneReach Biotechnology is expected to under-perform the Level Biotechnology. In addition to that, GeneReach Biotechnology is 2.26 times more volatile than Level Biotechnology. It trades about -0.03 of its total potential returns per unit of risk. Level Biotechnology is currently generating about 0.05 per unit of volatility. If you would invest  2,627  in Level Biotechnology on October 9, 2024 and sell it today you would earn a total of  583.00  from holding Level Biotechnology or generate 22.19% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	99.8%
Values	Daily Returns

GeneReach Biotechnology  vs.  Level Biotechnology

GeneReach Biotechnology

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days GeneReach Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

Level Biotechnology

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Level Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Level Biotechnology is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Pair Trading with GeneReach Biotechnology and Level Biotechnology

The main advantage of trading using opposite GeneReach Biotechnology and Level Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GeneReach Biotechnology position performs unexpectedly, Level Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Level Biotechnology will offset losses from the drop in Level Biotechnology's long position.

The idea behind GeneReach Biotechnology and Level Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.